Farallon Capital Management LLC Caribou Biosciences, Inc. Transaction History

Farallon Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$5.34 - $12.79 $6.98 Million - $16.7 Million	-1,307,526 Reduced 59.33%	896,369 $9.46 Million
Q2 2022 Aug 15, 2022	SELL	$5.1 - $9.74 $2.31 Million - $4.41 Million	-453,157 Reduced 17.05%	2,203,895 $12 Million
Q1 2022 May 16, 2022	SELL	$8.42 - $15.32 $2.58 Million - $4.69 Million	-306,396 Reduced 10.34%	2,657,052 $24.4 Million
Q3 2021 Nov 15, 2021	BUY	$15.75 - $30.29 $46.7 Million - $89.8 Million	2,963,448 New	2,963,448 $70.7 Million

135

52.6M

148K

70.7K

Ticker CRBU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,840,800
Market Cap $110M
Description
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.